Concepedia

Noriaki Tatsuta

NT

Statistics

Publications

15

Citations

946

H-Index

13

Active since

1989

Affiliations

Synta Pharmaceuticals (United States)(Current)

Dana-Farber Cancer Institute

Fujifilm (Japan)

Noriaki Tatsuta is an author at Synta Pharmaceuticals (United States) specializing in pharmacology, medicine, and oncology pharmacology.

Publications per year

1989–2020

15

Publications

15

Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

Weiwen Ying, Zhenjian Du, Lijun Sun et al. · Molecular Cancer Therapeutics · 2011 · 231 citations

, , +11

Phase I Clinical Trial of STA-4783 in Combination with Paclitaxel in Patients with Refractory Solid Tumors

Anna Berkenblit, Joseph P. Eder, David P. Ryan et al. · Clinical Cancer Research · 2007 · 120 citations

, , +15

Structure−Activity of Novel Rhodacyanine Dyes as Antitumor Agents

Masayuki Kawakami, Keizo Koya, Toshinao Ukai et al. · Journal of Medicinal Chemistry · 1998 · 102 citations

, , +11

Apilimod Inhibits the Production of IL-12 and IL-23 and Reduces Dendritic Cell Infiltration in Psoriasis

Yumiko Wada, Irma Cardinale, Artemis Khatcherian et al. · PLoS ONE · 2012 · 81 citations · Full text

, , +17

FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism

Jaime Acquaviva, Suqin He, Chaohua Zhang et al. · Molecular Cancer Research · 2014 · 76 citations

, , +16

1–5 of 15